Home / Azithromycin / United States
US ATC J01FA10 · updated 2 Nov 2026
Azithromycin shortage in United States
Is there an Azithromycin shortage in United States?
Yes. As of 2 Nov 2026, 3 Azithromycin products are reported short in United States, the first since 20 Jan 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Spain, Ireland, Switzerland, Czechia, Sweden, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Zithromax IV, Injection, 500 mg/5 mL (NDC 0069-3150-83) discontinuation | Pfizer Inc. | 20 Jan 2026 | not given | Not stated |
| US | Zithromax, Tablet, 250 mg (NDC 0069-4061-01) discontinuation | Pfizer Inc. | 9 Apr 2026 | not given | Not stated |
| US | Zithromax, Tablet, 500 mg (NDC 0069-3070-30) discontinuation | Pfizer Inc. | 9 Apr 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).